S&P 500 Technology Sector SEC Filings — April 01, 2026

01-04-2026

Community West Bancshares (CWBC) completed its merger with United Security Bancshares (UBFO) on April 1, 2026, in an all-stock transaction where UBFO shareholders received 0.4520 CWBC shares per UBFO share, valued at approximately $185.5 million based on CWBC's $23.30 closing price on March 31, 2026. The combined company has approximately $5 billion in total assets, retains banking offices across 13 counties and 31 communities in Central California, and features a 14-member board with 12 directors from CWBC and 2 from UBFO. Leadership transitions include James J. Kim as CEO and President, Daniel J. Doyle as Chairman, new Vice Chairman Jagroop “Jay” Gill, and Dennis R. Woods as Chairman Emeritus, alongside retirements of Suzanne M. Chadwick, Tom L. Dobyns, William S. Smittcamp, and upcoming Daniel C. Cunningham.

• ·Shareholder approvals at special meetings on March 30, 2026.
• ·Planned systems conversion in summer 2026.
• ·Exchange ratio: 0.4520 shares of CWBC common stock per share of UBFO common stock.
• ·This is the seventh acquisition for the company, following Community West Bancshares (2024), Folsom Lake Bank (2017), Sierra Vista Bank (2016), Visalia Community Bank (2013), Service 1st Bank (2008), and Bank of Madera County (2005).

01-04-2026

Community Health Systems, Inc. completed the sale of substantially all assets and certain liabilities of Crestwood Medical Center and associated outpatient centers in Huntsville, Alabama, to The Health Care Authority of the City of Huntsville d/b/a Huntsville Hospital Health System on April 1, 2026, for $459 million in cash (subject to post-closing adjustments). The transaction resulted in an estimated pre-tax gain of $185 million ($138 million after tax), boosting pro forma cash by $450 million and improving stockholders' deficit. However, pro forma net operating revenues declined by $327 million, and net loss attributable to stockholders increased to $610 million from $509 million for the year ended December 31, 2025.

• ·Agreement entered into on January 20, 2026.
• ·Facility operations do not qualify as discontinued operations under ASC 205.
• ·Pro forma adjustments eliminate $327M revenues, $123M salaries/benefits, $63M supplies, $88M other operating expenses, $11M lease cost, $13M depreciation/amortization, and reflect $185M gain/(loss) on sale.

01-04-2026

For the year ended December 31, 2025, Maui Land & Pineapple Co Inc (MLP) showed strong growth in Land Development and Sales revenues (+68% YoY to $19.5M) and Leasing revenues (over 1,000% YoY to $5.8M), while Resort Amenities revenues increased 23% YoY to $12.8M but operating income declined 6% YoY. However, an unidentified segment saw revenues drop 41% YoY to $0.8M with wider operating loss, and overall net loss expanded to $10.6M from $7.4M primarily due to $6.9M in pension expenses, with basic/diluted loss per share at $(0.54) vs $(0.38). Total land holdings remained at 22,286 acres across West and Upcountry Maui.

• ·West Maui land breakdown: 19 acres commercial/industrial, 866 acres residential/resort/mixed-use, 8,871 acres agricultural, 11,045 acres conservation/watershed.
• ·Land Development and Sales operating loss improved to $(4.5M) from $(7.4M) YoY.
• ·Leasing operating income swung to $1.8M profit from $(0.6M) loss YoY.
• ·Company reviews long-lived assets for impairment based on cash flow estimates and classifies assets as held for sale under specific criteria including management commitment and active marketing.

01-04-2026

Immunic, Inc. received notification from Nasdaq on March 27, 2026, confirming it has regained compliance with Listing Rule 5550(a)(2) Minimum Bid Price Requirement after maintaining a $1.00 per share closing bid price for 20 consecutive business days from February 27 to March 26, 2026, closing the matter. The company issued a press release on April 1, 2026, announcing this development. No negative performance metrics reported; the company highlighted its ongoing Phase 3 trials for vidofludimus calcium (IMU-838) with top-line data expected by end of 2026.

• ·Immunic's lead program vidofludimus calcium (IMU-838) in Phase 3 for relapsing multiple sclerosis.
• ·Pipeline includes earlier-stage programs IMU-856 and IMU-381 for neurodegenerative, chronic inflammatory, and autoimmune diseases.
• ·Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed February 26, 2026.

01-04-2026

Scinai Immunotherapeutics Ltd. reports a history of operating losses and lack of current profitability, despite generating revenues from its CDMO activities, with risks of continued losses due to market demand dependencies and partner performance issues. The company highlights competitive strengths in its dual business model combining R&D drug development with CDMO operations, which provides financial flexibility, generates external revenues, and supports internal programs to reduce cash burn. However, regulatory risks including state anti-kickback laws and partner failures could delay pipeline commercialization and impact revenues.

01-04-2026

Cottonwood Communities, Inc. reported sales of 239,119 shares of Series A Convertible Preferred Stock for $2,369,181 in gross proceeds during March 11-31, 2026, with $124,160 in commissions and $68,522 in placement fees paid. Additionally, the company sold 130,077 shares of Series 2025 Preferred Stock for $1,277,000 in gross proceeds over March 16-31, 2026, incurring $55,620 in commissions and $37,872 in placement fees. These sales are part of ongoing private placements with maximum offerings of $150,000,000 each.

• ·Offerings exempt under Rule 506(b) of Regulation D, sold solely to accredited investors without general solicitation.
• ·Series A Convertible launched September 19, 2023; Series 2025 launched December 9, 2024; both at $10.00 per share.

01-04-2026

ServiceNow, Inc. entered into a Credit Agreement dated April 1, 2026, acting as Borrower, with JPMorgan Chase Bank, N.A. as Administrative Agent and various lenders party thereto. The agreement establishes facilities for revolving borrowings, swingline loans, and letters of credit, governed by standard terms including representations, covenants, and events of default. No specific commitment amounts or financial metrics are detailed in the provided content.

• ·Filing Type: 8-K, Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)
• ·Filing Date: April 01, 2026
• ·Subcategory: Material Agreement Entry
• ·Schedules include Commitments (2.01), Swingline Commitments (2.04), Existing Letters of Credit (2.05A), LC Commitments (2.05B), Existing Liens (6.01), Existing Subsidiary Debt (6.03)

01-04-2026

Intuitive Machines, Inc. (LUNR) filed an 8-K/A amendment to provide audited historical consolidated financial statements of Lanteris Space Holdings LLC for the years ended December 31, 2025 and 2024 (Exhibit 99.1), and unaudited pro forma condensed combined financial information as of and for the year ended December 31, 2025 (Exhibit 99.2), following the consummation of its $800 million acquisition of Lanteris on January 13, 2026. The acquisition consideration consisted of $450 million in cash and $350 million in Class A Common Stock, pursuant to a purchase agreement dated November 3, 2025. No other changes were made to the original 8-K filed January 13, 2026.

• ·Acquisition first announced on November 4, 2025
• ·Membership Interest Purchase Agreement dated November 3, 2025
• ·Historical audited financials cover years ended December 31, 2025 and 2024
• ·Pro forma financials as of and for year ended December 31, 2025
• ·Consent of KPMG LLP filed as Exhibit 23.1

01-04-2026

abrdn National Municipal Income Fund (NYSE: VFL) adjourned its Special Shareholder Meeting on April 1, 2026, to April 15, 2026, at 11:00 am Eastern Time, to solicit additional proxies and achieve quorum. The meeting concerns approval of an Agreement and Plan of Reorganization with MFS Municipal Income Trust (NYSE: MFM), which the Board of Trustees unanimously recommends. Aberdeen Investments, the manager, had approximately $525 billion in assets under management as of December 31, 2025.

• ·Proxy materials available on www.sec.gov and via mail.
• ·Contact: Aberdeen Investments U.S. Closed-End Funds Investor Relations at 1-800-522-5465 or investor.relations@aberdeenplc.com

01-04-2026

On March 27, 2026, Lafayette Square USA, Inc. sold approximately 1.4 million shares of its common stock (par value $0.001 per share) to investors for an aggregate price of $20.9 million, pursuant to drawdown notices under existing subscription agreements. The sales were made on an as-needed basis up to investors' capital commitments and are exempt from Securities Act registration under Section 4(a)(2) and Regulation D, relying on investors' accredited investor status.

• ·Subscription agreements require investors to fund drawdowns up to their respective capital commitments.
• ·Company is an emerging growth company and has elected not to use the extended transition period for new financial accounting standards.

01-04-2026

Micron Technology, Inc. issued a press release on March 31, 2026, announcing the pricing of its cash tender offers for any and all outstanding senior notes, including 5.300% due 2031, 5.650% due 2032, 5.875% due 2033 (2033A and 2033B Notes), 5.800% due 2035 (2035A Notes), and 6.050% due 2035 (2023B Notes), which were commenced on March 25, 2026. On April 1, 2026, the Company announced the expiration of these tender offers via another press release. No specific tender amounts, acceptance levels, or pricing details were disclosed in the filing.

• ·Tender offers commenced on March 25, 2026.
• ·Press releases attached as Exhibit 99.1 (March 31, 2026) and Exhibit 99.2 (April 1, 2026).

01-04-2026

United Community Banks, Inc. (UCBI) has issued Definitive Additional Proxy Materials (DEFA14A) for its 2026 Annual Shareholder Meeting scheduled virtually on May 13, 2026, at 3:00 PM ET. Shareholders are voting on the election of 12 director nominees, advisory approval of Named Executive Officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026. Proxy materials are available online at www.ProxyVote.com or can be requested in paper/email form by April 29, 2026.

• ·Voting deadline: May 12, 2026, 11:59 PM ET (May 10, 2026, 11:59 PM ET for shares in a Plan)
• ·Virtual meeting URL: www.virtualshareholdermeeting.com/UCBI2026
• ·Company address: 200 East Camperdown Way, Greenville, South Carolina 29601
• ·Material request methods: www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)

01-04-2026

Darlington Partners Capital Management, LP, Darlington Partners GP, LLC, Darlington Partners, L.P., Scott W. Clark, and Ramsey B. Jishi filed Schedule 13G on April 1, 2026, disclosing beneficial ownership of 7,551,884 shares of Warner Music Group Corp.'s Class A Common Stock as of March 25, 2026, equating to 5.1% of the 146,965,855 shares outstanding per the company's Form 10-Q filed February 4, 2026, for the quarter ended December 31, 2025. The filers report the shares are held by investment adviser clients, including Darlington Partners, L.P., with no single client other than Darlington exceeding 5%. They file jointly but disclaim group membership or beneficial ownership beyond pecuniary interest, certifying passive investment not intended to influence control.

• ·Shares outstanding figure from Form 10-Q for quarter ended December 31, 2025.
• ·Filers certify holdings acquired and held in ordinary course of business, not for purpose of changing or influencing control.